Many functional assays require substantial quantities of purified
arrestin proteins that cannot be produced in cell-free
translation.
27 28 To establish a preparative expression
system for both arrestins and to characterize SalArr2 that failed to
express in the in vitro translation, we subcloned the ORFs of both
salamander arrestins and that of SalArr1(3A) mutant into the
E. coli expression vector pTrcHisB. SalArr1,
SalArr2, and SalArr1(3A) expressed reasonably well in BL21 cells,
yielding after our standard purification procedure
28 34,
5, and 2 mg of pure arrestin, respectively. To test the ability of
purified proteins to bind to frog rhodopsin, we used a centrifugation
assay
6 with subsequent quantitative Western blot
analysis
27 28 (Fig. 7) . We found that 80% ± 5%, 82% ± 6%, and 44% ± 7% of SalArr1,
SalArr1(3A), and SalArr2, respectively, bound to 1.5 μg of frog
P-Rh*. Only SalArr1(3A) demonstrated substantial binding to Rh*
(Fig. 7) , in agreement with our direct binding data
(Fig. 6) . To estimate the
percentage of functionally active arrestins in our preparations, we
performed similar experiments with 4.5 μg P-Rh* per assay, and found
that 100% ± 4%, 98% ± 5%, and 85% ± 3% of SalArr1,
SalArr1(3A), and SalArr2, respectively, bound under these conditions.
It is worth noting that comparable amounts of SalArr1 and SalArr1(3A)
mutant bound to 1.5 and 4.5 μg of P-Rh*, whereas the percentage of
bound SalArr2 increased dramatically with the threefold increase in
P-Rh* concentration. These data suggest that the affinity of SalArr1
for P-Rh* is substantially higher than that of SalArr2. Because 85% to
100% of
E. coli–expressed arrestins were found to be
functionally active, we next attempted to obtain a more quantitative
estimate of their relative affinities for P-Rh* in a direct binding
assay. In this assay [
3H]SalArr1 served as
radioligand, and purified
E. coli–expressed arrestins
served as competing ligands (
Figs. 8A 8B ). We also performed a similar series of experiments using[
3H]bovine visual arrestin (not shown). Under
the conditions used, SalArr1 and SalArr1(3A) inhibited[
3H]SalArr1 binding with
K i of 179 ± 27 and 74 ± 12
nM, respectively (corresponding
K i for
the inhibition of [
3H]bovine arrestin binding
were 540 ± 120 and 63 ± 9 nM, respectively). SalArr2
exhibited a dramatically lower affinity for frog P-Rh*, with
K i for the inhibition of[
3H]SalArr1 and[
3H]bovine arrestin binding being 9.1 ±
3.3 and 25.7 ± 2.6 μM, respectively. Thus, regardless of the
radiolabeled arrestin used, the affinity of SalArr2 for frog P-Rh* was
approximately 50 times lower than that of SalArr1, in agreement with
results in centrifugation experiments.